Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Catechol‐O‐methyltransferase Inhibitors Versus Active Comparators for Levodopa‐induced Complications in Parkinson's Disease Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol���O���methyltransferase_inhibitors_versus_active_comparators_for_levodopa���induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_. Accessed 27 June 2022.
Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol���O���methyltransferase_inhibitors_versus_active_comparators_for_levodopa���induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_. Accessed June 27, 2022.
Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol���O���methyltransferase_inhibitors_versus_active_comparators_for_levodopa���induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_
Catechol‐O‐methyltransferase Inhibitors Versus Active Comparators for Levodopa‐induced Complications in Parkinson's Disease Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 June 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol���O���methyltransferase_inhibitors_versus_active_comparators_for_levodopa���induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Catechol‐O‐methyltransferase inhibitors versus active comparators for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
ID - 431338
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Catechol���O���methyltransferase_inhibitors_versus_active_comparators_for_levodopa���induced_complications_in_Parkinson's_disease_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -